abstract |
The present invention relates to various prodrugs of monomethyl fumarate, which offer improved properties relative to dimethyl fumarate. The invention provides compounds of formula (Ia), and pharmaceutical compositions thereof, which are useful in the treatment of immunological, autoimmune, and inflammatory diseases and conditions, including multiple sclerosis. (see formula Ia) |